Prostatype Genomics AB Logo

Prostatype Genomics AB

Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.

PROGEN | ST

Overview

Corporate Details

ISIN(s):
SE0022574554 (+2 more)
LEI:
549300JO6MPCGPVHVU91
Country:
Sweden
Address:
Gustav III:s Boulevard 34, 169 73 Solna
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test, Prostatype®. The test is designed to provide a comprehensive assessment of the aggressiveness of diagnosed prostate cancer, particularly for patients with localized disease. It serves as a decision-making tool for clinicians and patients to help determine appropriate treatment strategies. The Prostatype® system uses existing biopsy tissue to analyze the expression of three key genes. This genetic data is combined with standard clinical parameters (PSA, Gleason Score, Tumor Stage) to calculate a proprietary P-score, which quantifies the risk of cancer mortality. By offering a more precise prognosis, the test aims to minimize both over- and under-treatment, thereby improving patient quality of life and saving healthcare resources.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Prostatype Genomics AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prostatype Genomics AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Condor Technologies NV Logo
Develops and manufactures dental intra-oral scanners for precise digital impressions.
Belgium MLMFI
Convatec Group PLC Logo
Develops medical solutions for chronic wound, ostomy, continence, and infusion care globally.
United Kingdom CTEC
Corentec Co., Ltd. Logo
Global developer and manufacturer of advanced orthopedic implants and artificial joints.
South Korea 104540
CREATE MEDIC CO.,LTD. Logo
Manufactures silicone medical supplies like catheters and tubes for global healthcare.
Japan 5187
CREO MEDICAL GROUP PLC Logo
Develops advanced energy electrosurgical devices for minimally invasive therapeutic endoscopy.
United Kingdom CREO
Develops implantable tech for localized chemotherapy delivery directly into solid tumors.
Virgin Islands (British) N/A
CS Medica A/S Logo
Develops patented, CBD-infused medical devices for pain, autoimmune, and stress relief.
Denmark CSMED
Cytogen, Inc. Logo
Developing liquid biopsy technology to isolate tumor cells for cancer diagnostics and research.
South Korea 217330
Cytori Cell Research Institute,Inc. Logo
Develops devices and cell therapies using a patient's fat tissue to repair injury and treat disease.
Japan 3750
DAIHAN SCIENTIFIC CO., Ltd Logo
Global provider of lab & medical solutions, from manufacturing to total care services.
South Korea 131220

Talk to a Data Expert

Have a question? We'll get back to you promptly.